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Human bodies in socio-cultural 
context
How societies treat the bodies of their members, including when 
they are dead, tells us a great deal about them. Stone Age burials, 
like those of the Egyptian rulers, show respect for the dead and 
beliefs in an afterlife. In our contemporary global village the patent-
ing of human tissue, and the public display of preserved corpses, 
reflect ways in which bodies have become yet another commod-
ity in what prominent psychoanalyst Erich Fromm refers to as our 
‘technicised’ society1,2 (among other things, Fromm2 looks at the 
relationship between society and necrophilia).
A defining characteristic of humanity is our capacity for ab-
stract thought, and our use of symbols to embody the meaning 
of the social reality which we construct. Rich in symbolism, rituals 
are integral to the milestones of life, especially birth and death, for 
ritual behaviour is ‘inevitably about time – its passage, its mean-
ing, and its inexorable association with decay and death as well as 
with images of rebirth, reincarnation or regrouping’.3
The humanity of Neanderthals (Homo neanderthalensis) was 
confirmed by the discovery of artificially dug graves (no easy task 
using stone tools on rocky ground), indicating funeral rites of some 
type.4 Stone Age burials too, including in southern Africa, show 
evidence of ritual and beliefs in an afterlife. Valuable goods were 
buried with the deceased, some gravestones were beautifully 
decorated, and bodies were positioned facing the rising sun in the 
east.5
Rare instances of cannibalism following death, including the 
opening of skulls to consume the brain, may seem contrary to no-
tions of respect for the dead. A modern example of this practice 
was reported by doctors working in an isolated area of Papua New 
Guinea, who traced a disease of the brain known as kuru, which 
was leading to large numbers of deaths in the area, to this prac-
tice.6 However, when such behaviour is viewed in the context of 
the body of shared ideas and understandings about the world – 
culture – of which they are part it can be understood as ritualistic, 
a type of communion involving the integration of deceased into the 
kinship network of which he or she was part.1,2,7
By contextualising such practices it becomes clear that they 
are very different to the type of mutilation and desecration deliber-
ately inflicted on the bodies of enemies, including the traitors with-
in one’s own societies – those accused of treason and witchcraft.8 
Consider, for example, the difference between the mass graves of 
Holocaust and other genocide victims to the dignified burials given 
to members of one’s own group.
Culture and human tissue in 
southern Africa
Cultural norms, values and beliefs impact in very significant ways 
in matters relating to the human body, especially as they relate to 
birth, death, health and illness. However, although broad patterns 
of these ‘shared understandings’ are evident, individual interpre-
tations (within a linguistic group or region) vary. Culture is also 
dynamic, especially in times of rapid social change.
In the indigenous farming societies in southern Africa burial, 
surrounded by elaborate rites, has been the norm during recorded 
history (see e.g. Ngubane9). These practices are linked to beliefs 
and rituals centring around ancestral veneration, which are found 
in most societies in Africa, and many elsewhere in the world. While 
ancestral graves are regarded as sacred, it is accepted that they 
may need to be abandoned as people move elsewhere (as oc-
curred during much of history), and there are specific rituals which 
keep the ancestors informed, and allow them to remain a pres-
ence in the lives of their descendants.
Burial serves to protect the bodies of the deceased not only 
from the predatory activities of wild animals, but also from witches 
and sorcerers who, through access to body parts of deceased rel-
atives, are believed to be able to inflict dreadful harm on living fam-
ily members. Edwards describes how, in the Eastern Cape, ants 
collected from graves, which are presumed to have been eating 
the flesh of the deceased – or even blood from an accident or mur-
der scene – have been used to prepare medicine to induce a type 
of spirit possession known as amafufunyana in one’s enemies.10 
Beliefs in spirits and witchcraft (found, in different forms, in all 
societies), and the need to obtain different types of medicine to 
either harm one’s enemies or protect oneself from such threats, 
fuel trade in body parts, taken from living or dead people. That 
there is a vigorous trade in body parts between South Africa and 
Mozambique, which is documented in a recent report by the Hu-
man Rights League, Mozambique, is therefore hardly surprising.11 
Of the thousands of murders in South Africa every year some 
appear motivated by the need for body parts, which are removed 
either before or after death. Also of concern is the apparent failure 
to supervise or monitor those whose job it is to care for the living 
and the dead. During 2010 decomposing bodies of two women 
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were discovered in two different hospitals in Durban – Prince Mshi-
yeni at Umlazi, and Addington in central Durban. Also reported was 
the disappearance of the body of an infant from the mortuary at 
Prince Mshiyeni Hospital.12,13 During a recent public sector strike, 
mortuary workers at Magwaza Maphalala (Gale) Street mortuary 
in Durban embarked on a deliberate programme to sabotage fo-
rensic operations, including switching off fridges and muddling the 
name tags on corpses, showing contempt for the human remains 
entrusted to their care.14 There are longstanding complaints about 
the conduct of staff members at this state facility which the De-
partment of Health has failed to address, and cases of insurance 
fraud using unidentified bodies are reportedly under investigation 
by the police. Whether or not allegations of dealings in body parts 
between certain staff and umuthi (medicine) sellers in Durban are 
true, the lack of proper management at this facility would facilitate 
such dealings.15
Culture and power in southern Africa
Although culture is of crucial importance it cannot in itself explain 
human behaviour unless it is considered together with the struc-
ture of society, i.e. the network of relationships among its mem-
bers, the status of whom varies greatly in terms of their access to 
socio-economic and political power.
Like anatomists dissecting a human body, social scientists use 
tools to try to understand and explain the workings of the social 
body, society. However, unlike those used by anatomists, the tools 
used for this purpose – such as culture and social structure – are 
simply concepts. While it is acceptable to use the term ‘cultures’ as 
a heuristic device (although it is more accurate to talk about socie-
ties), it is a distortion to accord these supposed entities some sort 
of objective reality dissociated from the human consciousnesses 
from which they are abstracted.
This point is important because in South Africa this term has 
been (and still is) badly abused, especially for political purposes. 
Not only was it employed by the apartheid state to disguise the 
racial basis of its homeland system, but it was also used to try 
to justify a special political status for what is now KwaZulu-Natal, 
linked to the historic Zulu nation.16 After so many years of racial 
separation and indoctrination, it is not surprising that culture and 
ethnicity, like race, continues to receive undue prominence in 
South Africa. The ethnos approach to this concept, which under-
pinned apartheid and equated race with culture and nation, had its 
roots in the very same Scientific Racism of the 19th and early 20th 
century that spawned Nazism. After the atrocities perpetrated in its 
name during World War II it disappeared from political discourse 
everywhere in the world, except for apartheid South Africa and the 
former Soviet Union.17 
It was this ideology too, together with its close associate Social 
Darwinism (that societies occupy different rungs on the evolution-
ary ladder), which led to many southern African Bushmen (San) 
being exhibited in Europe during the 19th century.18 Among them 
was Sarah (‘Saartjie’) Baartman whose ‘well preserved, articulated 
and mounted skeleton’ as well as brain and external genitalia re-
mained on display in a French museum until relatively recently, 
and whose remains were finally, with some difficulty, repatriated to 
South Africa in 2002.19
The treatment meted out to Baartman and others viewed as 
being of inferior races is explicable only in terms of the gross im-
balances of power, and the ideology which justified it, of the period 
in which these events took place.
Although the world has changed dramatically in the past 
century, the degree of control one is able to exercise over what 
happens to one’s body while alive and dead – access to health 
care, the type of burial relatives can afford – remains a function of 
one’s status in society. Issues relating to the use of human tissue 
in South Africa, and ethics surrounding this use, also need to be 
placed in the context of globalisation.
The global context
The 1999 Human Development Report published for the United 
Nations describes the contemporary market-driven world as one in 
which ‘trade, patents and copyright’ determine not only the paths 
of technology but also those of nations.20 Global markets are domi-
nated by powerful multinationals, some of which have more eco-
nomic power than some nations.21
Pharmaceutical companies are among the most powerful of 
these global players, and wield an extraordinary amount of influ-
ence, including over what is published in the media22 (see espe-
cially chapters 33 and 34) and even in leading medical journals.23 
They also fund a great deal of research.
Recent decades have seen the exponential growth in the ap-
propriation of intellectual property rights by both individuals and 
multinationals, including pharmaceuticals, and the growing num-
bers of biotechnology companies. This development has been 
compared to the historical enclosure movement of Europe, which 
saw ordinary people deprived of their common property and 
means of subsistence.24 For the past 20 years, the overwhelming 
majority of patents registered have been held by several indus- 
trialised and, more recently, industrialising nations (China, Repub-
lic of Korea). In 2005 the largest number of patents granted were 
in the USA.20,25
Human genes are among the items patented. The Council for 
Responsible Genetics (CRG) cites research showing that in 2005 
almost 20% of human genes were claimed by USA patents, as 
well as subsequent research suggesting that the percentage is 
actually higher. Universities and research institutes, as well as 
pharmaceutical and biotechnology companies, are among those 
holding such patents.26 
According to one projection, commercial developments linked 
to the Human Genome Mapping Project – described by UNESCO 
as the common heritage of humanity – were expected to reap 
sales of $60 billion worth of products per annum by 2010.27
If, as the CRG argues, ‘bioprospecting’ – ‘the hunt for new 
genes to exploit for profit’ – is indeed ‘a vast new frontier for sci-
ence and industry’, what are the implications for South Africa?28
South Africa and the global health 
industry
South Africa remains among the most unequal societies – if not 
the most unequal – in the world.29 Large sectors of society, espe-
cially in impoverished rural areas, are still disempowered. True de-
mocracy has not taken root, especially in areas in which violence 
levels are high, and people fear to express themselves freely. 
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In matters pertaining to health power differentials play them-
selves out in various ways, including the type of health services 
one can afford, and relationships between health professionals 
and patients/research participants. 
Research, including by overseas-based researchers, has 
grown dramatically in the past 20 years, largely because of the 
extremely high rates of HIV/AIDS and tuberculosis in South Africa. 
The vast majority of this research takes place in poor communities 
in which people use public health facilities (hospitals and clinics), 
and where people are often uninformed about their medical rights, 
especially relative to those who are better off, and who have ac-
cess to the internet and medical reference works. 
In rural areas under traditional leadership there are further 
power dynamics that impact on health. This essentially feudal sys-
tem is not a democratic one, since appointment to this office is 
theoretically based on heredity but has, since colonial times, also 
been subject to political manipulation. The conduct of these lead-
ers varies greatly – some strive to run their fiefdoms in a demo-
cratic manner, but most are extremely autocratic, some ruling by 
fear (see the example of Macambini Traditional Authority in KZN 
reports30). Although a few of these traditional leaders are now fe-
male, rural women in general enjoy little power, particularly in KZN 
where the legacy of codified customary law which diminished the 
status of women lingers.
When research takes place in such communities – for example, 
at the Africa Centre based at Hlabisa, northern KZN – research-
ers usually consult with, and obtain permission from, such leaders 
before proceeding with research. The leader may thus exert pres-
sure on members of his constituency to participate in the research.
In much of the collaborative research involving overseas-
based partners, it is common for human tissue samples, including 
(but not exclusively) blood, to be sent to laboratories, including in 
the USA. The poor thus become legal suppliers of human tissue 
– transforming themselves, through their involvement in medical 
research, into ‘valued objects’.1
HIV vaccine research illustrates how the poor become the tar-
gets of medical researchers. 
An initial vaccine trial run by the MRC in Durban, which solic-
ited volunteers across the socio-economic spectrum, was closed 
down in 2005. Few volunteers had been enrolled, and there were 
concerns that the site of the trial (Durban) was ‘not in a commu-
nity where it would be easy to recruit large numbers of volunteers 
needed for Phase II and III trials’.31,32 
In 2007 comment was invited from interested parties about the 
proposed vaccine trial of ‘genetically modified organism’ at a num-
ber of sites countrywide serving mainly black Africans, including 
vulnerable mineworkers.33,34
Despite the high number of people to be recruited – 3 000 – 
the African Centre for Biosafety (ACB), which made a submission 
about the trial, experienced a ‘lack of information in the public 
domain’. It proved impossible for the ACB to obtain information 
necessary to launch a PAIA (Promotion of Access to Information) 
application in time for its submission. Obstacles included the un-
willingness of the vaccine manufacturer, Merck & Co, and the Na-
tional Institutes of Health (NIH) in the USA, to assist, and delays 
by various South African bodies, including the Medicines Control 
Council (MCC).35 Working on the sketchy data provided in press 
reports, the ACB raised a number of concerns in its detailed sub-
mission to the Registrar, and called for the application of the ‘pre-
cautionary principle’ and ‘for a moratorium on clinical trials of AIDS 
vaccines based on adenoviral vectors’.35 The Third World Network 
echoed this call.36
These calls were ignored and in January 2007 a start was 
made with enrolling and vaccinating participants.37 In September 
2007 the trial (dubbed the Phambili trial) was paused and, in Oc-
tober, suspended, after similar trials in the USA showed signs that 
‘the vaccine somehow raised the risk of infection’.37,38 In November 
2007 a weekly newspaper reported that there was a scramble to 
locate all participants to ascertain how many volunteers had be-
come infected while participating in the trial (only 220 of the 308 
participants in Soweto had been located at that stage).39 
Since the sponsors in this research were American-based, at 
least some of the specimens taken probably left the country. Per-
mission to take specimens must be given as part of the informed 
consent process and, in terms of international ethical norms, ad-
ditional permission must also be obtained if specimens are to be 
stored, with the option of consent being withdrawn at a later stage. 
While this rule applies in principle, once the samples have left the 
country oversight into what happens to them is lacking – raising 
questions about whether they end up as the intellectual property 
of a researcher, a university, or a pharmaceutical or biotechnology 
company.
Given the ease with which patents are granted in the USA, and 
the scramble to patent human genetic material, the loss of control 
over human tissue when it leaves South Africa is of great concern. 
Access to an individual’s genetic code through human tissue sam-
ples is an invasion of privacy – both individual and family – and 
should only be allowed with the full knowledge, consent and con-
trol of the owner. How many poor people understand the potential 
implications of allowing their DNA to be used for research pur-
poses? Do they know that the whole genome can be ‘scanned for 
all personal biological details coded by the genes’, that extracted 
DNA sequences can be cloned and used for a variety of purposes, 
and that they may hold huge commercial value?40 If donors do 
not fully understand these implications of providing specimens can 
they be said to have given truly informed consent?
Although financial incentives to participate in research are not 
permitted, there is a thin dividing line between ‘compensation’ for 
time and travel and incentive. This compensation is itself an in-
ducement to poor people to participate. The Medical Research 
Council (MRC) guidelines, for example, stipulate a sum of R150 
per visit by the participant to the research site, which is a signifi-
cant sum of money for an unemployed man or woman. Addressing 
a microbicide conference in Cape Town in April 2006, controversial 
former Minister of Health, the late Dr Manto Tshabalala-Msimang, 
correctly raised concerns about the possibility of financial com-
pensation acting as a ‘perverse incentive’ in poor communities.41 
It subsequently became apparent that women were enroll-
ing for more than one clinical trial as a means of earning money. 
Hlongwa and Zulu describe how participation in a microbicide trial 
had become a ‘money-making scheme’ for some young Durban 
women. Umlazi resident Zama Ncwane is quoted as having ad-
mitted to ‘having been attracted by the money’, saying she had 
‘registered in three of the MRC sites using three different names’ 
for research she claimed she did not understand.42 This particular 
trial was subsequently terminated early amid adverse publicity.43 
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At another MRC site testing microbicides, in North West prov-
ince, teenage girls were reported to be ‘bunking school’ to visit a 
research centre and participate in the research. They were being 
paid a total of R1 700 over the 2-year research period.44
Although research involving human subjects may not take 
place without the approval of ethics committees, there is a con-
spicuous lack of oversight, and no independent monitoring of this 
type of research, in South Africa.
While not minimising the importance of collaborative research, 
two caveats are relevant: Firstly, how are HIV- and tuberculosis-
infected people in general benefiting from the many millions of dol-
lars that have been poured into research on these potentially lethal 
diseases? If, for example, the Merck vaccine had been shown to 
be effective, would South Africa have had to expend huge sums of 
money to purchase it at going rates, despite much of the research 
on the human subjects having taken place here? Would partici-
pants who contracted HIV while on the study receive top-quality 
antiretrovirals from the sponsors, or would they be referred to state 
health facilities?
Secondly, it is not clear why specimens are being sent out of 
the country. Why, if it is lacking, is appropriate technology not in-
stalled, and capacity developed, to conduct what tests are needed 
on research specimens (especially as, historically, South Africa 
has been among world leaders in medical technology, including 
in its pioneering work on heart transplants)? Why this dependency 
on overseas expertise and technology when, as the CRG points 
out, ‘Patents held by the industrialized world on resources from the 
developing world will serve as a tool for the North to accumulate 
more wealth from the already economically impoverished South.’28 
Saartjie Baartman, opines Phillip Tobias, ‘epitomises an entire 
epoch of racial repression and colonial subjugation’.19 Those ex-
hibiting Baartman and others also profited from her degradation 
and that of other indigenous Africans. If powerful multinationals, 
and foreign-based institutions and individuals, are now profiting 
from the commercialisation of human tissue supplied by poor 
South Africans, have we not simply swopped one type of colonial-
ism for another, in the form of bio-colonialism?
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